Neoadjuvant chemoradiation changes podoplanin expression in esophageal cancer patients

Table 3 Podoplanin expression and tumor progression

Resected tissue	Score	Podoplanin, %	Patients, n	Patients, %
pT2, n = 6	1	0-5	5	83
	2	6-35	1	17
	3	36-65	0	0
pT3/4, n = 26	1	0-5	11	43
	2	6-35	10	38
	3	36-65	5	19
pN0, n = 11	1	0-5	7	64
	2	6-35	2	18
	3	36-65	2	18
pN+, n = 21	1	0-5	9	43
	2	6-35	9	43
	3	36-65	3	14

Resected tumor specimen of non-pretreated primary surgery squamous cell carcinoma of the esophagus patients, n = 32; pT: Pathologic tumor category; pN0: No lymph node metastases; pN+: Lymph nodes involved, scoring by immunohistochemical staining of D2-40.